Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cel-Sci Corp. (CVM)
NYSE MKT:CVM
Holding CVM?
Track your performance easily
CVM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.54 - $3.23
Previous Close$0.63
Volume216.82K
Average Volume (3M)352.73K
Market Cap
$41.17M
Enterprise Value$53.30M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$12.13M
Price to Earnings (P/E)―
Beta2.25
Next Earnings
Dec 18, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding61,493,229
10 Day Avg. Volume687,504
30 Day Avg. Volume352,728
Standard Deviation0.27
R-Squared0.02
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)4.49
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cel-Sci News
PremiumMarket News
3 Penny Stocks to Watch Now, 7/30/24
Ownership Overview
2.50% Insiders
4.78% Mutual Funds
1.13% Other Institutional Investors
87.76% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CVM FAQ
What was Cel-Sci Corp.’s price range in the past 12 months?
Cel-Sci Corp. lowest stock price was $0.54 and its highest was $3.23 in the past 12 months.
What is Cel-Sci Corp.’s market cap?
Currently, no data Available
When is Cel-Sci Corp.’s upcoming earnings report date?
Cel-Sci Corp.’s upcoming earnings report date is Dec 18, 2024 which is in 26 days.
How were Cel-Sci Corp.’s earnings last quarter?
Cel-Sci Corp. released its earnings results on Aug 15, 2024. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.14.
Is Cel-Sci Corp. overvalued?
According to Wall Street analysts Cel-Sci Corp.’s price is currently Overvalued.
Does Cel-Sci Corp. pay dividends?
Cel-Sci Corp. does not currently pay dividends.
What is Cel-Sci Corp.’s EPS estimate?
Cel-Sci Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cel-Sci Corp. have?
Cel-Sci Corp. has 63,807,102 shares outstanding.
What happened to Cel-Sci Corp.’s price movement after its last earnings report?
Cel-Sci Corp. reported an EPS of -$0.14 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.87%.
Which hedge fund is a major shareholder of Cel-Sci Corp.?
Currently, no hedge funds are holding shares in CVM
---
Cel-Sci Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-74.04%
12-Months-Change
Fundamentals
Return on Equity
-244.53%
Trailing 12-Months
Asset Growth
-25.53%
Trailing 12-Months
Company Description
Cel-Sci Corp.
CEL-SCI Corp. is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients; and CEL-2000 and CEL-4000 which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.
---
Technical Analysis
Inovio Pharmaceuticals
―
Advaxis
―
Northwest Biotherapeutics
―
Cyclacel Pharmaceuticals
―
---